Veterinary Medicines

Interceptor Flavor 2,3 mg tablets for dogs

Authorised
  • Milbemycin oxime
Download as PDF

Product identification

Medicine name:
Interceptor Flavor 2,3 mg tablets for dogs
Interceptor vet. 2,3 mg tabletti
Active substance:
  • Milbemycin oxime
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    2.30
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:
  • Cardboard box with 5 double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 6 tablets
  • Cardboard box with two double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 4 tablets
  • Cardboard box with double sided aluminium blister consisting of aluminium forming and lidding foils containing 6 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Novartis Sante Animale
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 27570
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0124/001
Concerned member states:
  • Denmark
  • Finland
  • Greece
  • Norway
  • Portugal
  • Spain
  • Sweden

Documents

Combined File of all Documents

English (PDF)
Published on: 12/05/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 25/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."